With government austerity tightening budgets in Europe, the solar industry is finding that tight times mean less for subsidies. Several countries in Europe in the past year have either severely reduced or outright dropped feed-in tarrifs for solar power generation. Looking for a more sure thing, governments have dedicated more of those�subsides�toward fossil fuels, which, according to the International Energy Agency, received almost $5.94 for every dollar spent on solar.�
Despite all of these moves, the solar industry is starting to find its own without those subsidies. With major utilities like Southern (NYSE: SO ) and Warren Buffett's Berkshire Hathaway all buying into solar in recent weeks, there are some strong signs that the cost to produce from solar could be in the same conversation as fossil fuels. In this video, Fool.com contributor Tyler Crowe talks with Aimee Duffy to look at some of the places solar feels a little less welcome and how it is finding�success�on its own.
Best India Stocks To Watch Right Now: Lancaster Colony Corporation(LANC)
Lancaster Colony Corporation engages in the manufacture and marketing of consumer products focusing primarily on specialty foods for the retail and foodservice markets in the United States. The company operates in two segments, Specialty Foods, and Glassware and Candles. The Specialty Foods segment produces and sells food products, including salad dressings and sauces under the Marzetti, T. Marzetti, Cardini?s, Pfeiffer, and Girard?s brands; fruit glazes, vegetable dips, and fruit dips under T. Marzetti brand; Greek yogurt vegetable dips under the Otria brand; frozen breads under New York BRAND and Mamma Bella brands; frozen Parkerhouse style yeast dinner rolls and sweet rolls, as well as biscuits, under the Sister Schubert?s, Marshall?s, and Mary B?s brands; premium dry egg noodles under the Inn Maid and Amish Kitchen brands; frozen specialty noodles and pastas under the Reames and Aunt Vi?s brands; croutons and related products under the New York BRAND, Texas Toast , Chatham Village, Cardini?s, and T. Marzetti brands; and caviar under the Romanoff brand. This segment markets its products through sales personnel, food brokers, and distributors to retail, club store, foodservice, and industrial markets. The Glassware and Candles segment produces and markets candles, candle accessories, and other home fragrance products in various sizes, forms, and fragrance in retail markets to mass merchants, supermarkets, drug stores, and specialty shops under the Candle-lite brand name. This segment also sells candles, glassware, and various other products to customers in commercial markets, including restaurants, hotels, hospitals, and schools. The company was founded in 1961 and is based in Columbus, Ohio.
Advisors' Opinion:- [By Rich Duprey]
Specialty-foods maker�Lancaster Colony� (NASDAQ: LANC ) �announced yesterday�its second-quarter dividend of $0.40 per share, a 5% increase over the $0.38 per share payout it's made the last two quarters. It marks the 200th consecutive dividend payment it has made putting it in elite company, as only 16 other companies have�increased its regular cash dividend each year for 50 consecutive years.
Top 10 Healthcare Equipment Stocks To Buy For 2014: Whiting USA Trust I(WHX)
Whiting USA Trust I is a REIT. The trust was founded in 2007 and is based in Austin, Texas.
Advisors' Opinion:- [By Roberto Pedone]
Another name that's starting to move within range of triggering a big breakout trade is Whiting USA Trust I (WHX). This stock hasn't done much so far in 2013, with shares up just 4.5%.
If you look at the chart for Whiting USA Trust I, you'll notice that this stock has been uptrending strong for the last few weeks, with shares moving higher from its low of $3.65 to its intraday high of $4.87 a share. During that move, shares of WHX have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now spiked shares of WHX back above both its 50-day and 200-day moving averages, which is bullish. Shares of WHX are now quickly moving within range of triggering a big breakout trade.
Traders should now look for long-biased trades in WHX if it manages to break out above some near-term overhead resistance levels at $4.90 to $5.04 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 321,220 shares. If that breakout triggers soon, then WHX will set up to re-test or possibly take out its next major overhead resistance levels at $6.23 to $8.01 a share.
Traders can look to buy WHX off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $4.12 a share. One can also buy WHX off strength once it takes out that breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Top 10 Healthcare Equipment Stocks To Buy For 2014: Exone Co (XONE)
The ExOne Company, incorporated on December 21, 2012, is engaged in manufacturing and selling three-dimensional (3D) printing machines and printing products to specification for its customers using its in-house 3D printing machines. The Company provides 3D printing machines, 3D printed products and related services to industrial customers in the aerospace, automotive, heavy equipment, energy/oil/gas and other industries. It offers pre-production collaboration and print products for customers through its production service centers (PSCs), which are located in the United States, Germany and Japan. On January 1, 2013, the Company merged its predecessor company, The Ex One Company, LLC, with and into EXO Acquisitions Inc., which changed its name to The ExOne Company.
The Company produces an array of materialization systems to support a range of customer needs and facility requirements. It offers two printers on the world market for 3D printing of sand and metal materials, offering build sizes as large as 1800 x 1000 x 700 mm (70 x 39 x 27 in.) for sand and 780 x 400 x 400 mm (30.7 x 15.75 x 15.75 in.) for metal. It also offers Orion short pulse laser systems, utilizing a five-axis machine tool with four additional axes available on the trepanning head. The Company builds 3D printing machines at its facilities in the United States and Germany. The Company also supplies the associated products, including consumables and replacement parts, and services, including training and technical support, necessary for purchasers of its machines to print products. The Company�� 3D printing machines are able to manufacture casting molds and cores from specialty silica sand and ceramics, which are the traditional materials for these casting products.
The Company competes with 3D Systems Corporation, Stratasys Inc., Solidscape, Inc. and Objet Ltd., EOS Optronics GmbH, EnvisionTEC GmbH, and Solid Model Ltd.
Advisors' Opinion:- [By Keith Fitz-Gerald]
There's also the ExOne Co. (Nasdaq: XONE). It develops, manufactures, and sells 3D printing machines around the world with an emphasis in the aerospace, automotive, and energy sectors that Tibbets called out as immediate beneficiaries.
Top 10 Healthcare Equipment Stocks To Buy For 2014: Rambus Inc.(RMBS)
Rambus Inc. engages in the creation, design, development, and licensing of patented innovations, technologies, and architectures to digital electronics products and systems. Its patented innovations include Dual Edge Clocking, which is designed to allow data to be sent on the clock pulse; Variable Burst Length that improves data transfer efficiency by allowing varying amounts of data to be sent per a memory read or write request in dynamic random access memory (DRAM) and flash memory; and FlexPhase technology, which synchronizes data output and compensates for circuit timing errors. The company also offers Channel Equalization to improve signal integrity and system margins in high speed parallel and serial link channels; Module Threading, which improves the power efficiency of a memory module by applying parallelism to module data accesses; and MicroLens optical design technology, which provides optimum utilization of high-brightness light-emitting diodes (LED) in edge-lit lighting applications. In addition, it licenses its architectures and industry-standard solutions for use in digital electronics products and systems, including XDR Memory Architecture enabling the production of DRAM; XDR2 Memory Architecture that incorporates DRAM micro-threading for graphics intensive applications, such as gaming and digital video; Mobile XDR Memory Architecture, which enables applications, such as HD video recording and 3D gaming on battery powered mobile devices; RDRAM Memory used in play stations, Intel-based personal computers, televisions, and routers; and FlexIO Processor Bus, a high speed chip-to-chip interface. Further, the company offers industry-standard chip interface solutions, including DDRx; digital logic controllers for peripheral component interconnect express and other industry standard interfaces; and custom solutions for displays, LED backlights, and general lighting. Rambus Inc. was founded in 1990 and is headquartered in Sunnyvale, Ca lifornia.
Advisors' Opinion:- [By Roberto Pedone]
Rambus (RMBS) is a technology solutions company that brings invention to market. This stock closed up 4% to $9.25 in Tuesday's trading session.
Tuesday's Range: $8.85-$9.39
52-Week Range: $4.01-$10.85
Tuesday's Volume: 1.93 million
Three-Month Average Volume: 960,806From a technical perspective, RMBS soared notably higher here back above its 50-day moving average of $9.09 with heavy upside volume. This move also pushed shares of RMBS into breakout territory, since it took out some near-term overhead resistance levels at $9.17 to $9.24. This stock has been uptrending strong for the last month and change, with shares moving higher from its low of $7.95 to its intraday high of $9.40. During that move, shares of RMBS have been making mostly higher lows and higher highs, which is bullish technical price action.
Traders should now look for long-biased trades in RMBS as long as it's trending above some near-term support levels at Tuesday's low of $8.85 to $8.87 and then once it sustains a move or close above Tuesday's high of $9.40 with volume that hits near or above 960,806 shares. If we get that move soon, then RMBS will set up to re-test or possibly take out its next major overhead resistance levels at $10 to its 52-week high at $10.85 Any high-volume move above $10.85 will then put $12 into range for shares of RMBS.
- [By Jake L'Ecuyer]
Rambus (NASDAQ: RMBS) was down, falling 6.02 percent to $11.56 after the company reported Q1 earnings of $0.17 per share on revenue of $78.30 million. Rambus also expected Q2 sales of $69.0 million to $74.0 million, versus analysts' estimates of $74.50 million.
- [By Wallace Witkowski]
Shares of Rambus Inc. (RMBS) �declined 8.5% to $11.25 on moderate volume after the company reported adjusted earnings of 17 cents a share on revenue of $78.3 million. Analysts expected 4 cents a share on revenue of $74.3 million. However, Rambus forecast second-quarter revenue of between $69 million and $74 million, while analysts expect $74.3 million.
- [By Monica Gerson]
Rambus (NASDAQ: RMBS) declined 6.50% to $11.50 after the company reported Q1 earnings of $0.17 per share on revenue of $78.30 million. Rambus also expected Q2 sales of $69.0 million to $74.0 million, versus analysts' estimates of $74.50 million.
Top 10 Healthcare Equipment Stocks To Buy For 2014: Impac Mortgage Holdings Inc (IMH)
Impac Mortgage Holdings, Inc. (IMH), incorporated in August 1995, operations include the mortgage and real estate fee-based business activities conducted by its subsidiaries: Integrated Real Estate Service Corporation (IRES), IMH Assets Corp. (IMH Assets) and Impac Funding Corporation (IFC). The Company�� operations include the mortgage and real estate fee-based business activities conducted by IRES and the long-term mortgage portfolio (residual interests in securitizations reflected as net trust assets and liabilities in the consolidated balance sheets. The mortgage lending activities include the origination, funding, selling and servicing of loans. The Company is focusing on originating loans eligible for sale to Fannie Mae and Freddie Mac, and government sponsored loans eligible for Ginnie Mae securities issuance.
Mortgage and real estate services
The Company created IRES to provide solutions to the mortgage and real estate markets. IRES performs services for investors, portfolio managers, servicers and individual borrowers, including mortgage lending services, portfolio monitoring and real estate services, surveillance and recovery services. The platform includes the mortgage lending operations, the portfolio loss mitigation and real estate services and formerly the title and escrow operations. The mortgage lending activities include the origination, funding, selling and servicing of loans. The Company is focusing on originating loans eligible for sale to Fannie Mae and Freddie Mac, and government sponsored loans eligible for Ginnie Mae securities issuance.
Master Servicing
In the ordinary course of business, the Company sells mortgage loans to the secondary market. The Company retains servicing on certain loans sold and earns servicing fees generally between 0.25% and 0.44% per annum of the monthly outstanding principal balance of the loans serviced. The Company has hired a nationally recognized residential sub-servicer to sub-service! the servicing portfolio. Although the Company uses a sub-servicer to provide primary servicing and certain default servicing functions, the Company's default management team, experienced in loss mitigation and real estate recovery, monitors and surveys the performance of the mortgage servicing portfolio. Incurring the cost of both a sub-servicer and an internal default management team reduces net servicing income, but it is an important investment used to minimize delinquencies and minimize repurchase risk. As of December 31, 2011, the total unpaid principal balance of mortgage loans serviced was $605.4 million.
Long-Term Mortgage Portfolio
The long-term mortgage portfolio consists of the residual interest in securitizations represented on the consolidated balance sheet as the difference between trust assets and trust liabilities. The long-term mortgage portfolio includes adjustable rate and fixed rate Alt-A single-family residential mortgages and commercial (primarily multifamily residential loans) mortgages that were acquired and originated by the Company. Alt-A mortgages are primarily first lien mortgages made to borrowers whose credit is within typical Fannie Mae and Freddie Mac guidelines, but have loan characteristics that make them non-conforming under those guidelines. Commercial mortgages in the long-term mortgage portfolio are adjustable rate mortgages with initial fixed interest rate periods of two-, three-, five-, seven- and 10-years that subsequently convert to adjustable rate mortgages (hybrid ARMs).
Advisors' Opinion:- [By Roberto Pedone]
Another stock that insiders are active in here is Impac Mortgage (IMH), which offers residential mortgage services in the U.S. Insiders are buying this stock into big time weakness, since shares are off by 27.4% so far in 2013.
Impac Mortgage has a market cap of $89 million and an enterprise value of $6.05 billion. This stock trades at a premium valuation, with a forward price-to-earnings of 124.10. This is not a cash-rich company, since the total cash position on its balance sheet is $14.15 million and its total debt is a whopping $5.98 billion.
A beneficial owner just bought 77,863 shares, or about $782,000 worth of stock, at $10 to $10.05 per share.
From a technical perspective, IMH is currently trending below both its 50-day and 200-day moving averages, which is bearish. This stock has been trending sideways in a consolidation pattern for the last month, with shares moving between $9.80 on the downside and $10.90 on the upside. A high-volume move above the upper-end of its sideways trading chart pattern soon could trigger a big breakout trade for shares of IMH.
If you're bullish on IMH, then look for long-biased trades as long as this stock is trending above some key near-term support at $9.80 and then once it breaks out above some near-term overhead resistance levels at $10.50 to $10.90 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 29,759 shares. If that breakout triggers soon, then IMH will set up to re-test or possibly take out its next major overhead resistance levels at $11.88 to $11.95. Any high-volume move above those levels will then give IMH a chance to tag $14.
Top 10 Healthcare Equipment Stocks To Buy For 2014: Canadian Pacific Railway Limited(CP)
Canadian Pacific Railway Limited, through its subsidiaries, operates as a transcontinental railway providing freight transportation services, logistics solutions, and supply chain expertise in Canada and the United States. It transports bulk commodities, including grain, coal, sulphur, and fertilizers; merchandise freight; finished vehicles and automotive parts; forest products, which include wood pulp, paper, paperboard, newsprint, lumber, panel, and oriented strand board; and industrial and consumer products comprising chemicals, energy, and plastics, as well as mine, metals, and aggregates. The company provides rail and intermodal transportation services over a network of approximately 14,700 miles serving the principal business centers of Canada, from Montreal to Vancouver, British Columbia; and the Midwest and Northeast regions of the United States. Canadian Pacific Railway Limited was founded in 1881 and is headquartered in Calgary, Canada.
Advisors' Opinion:- [By Matt DiLallo]
The biggest concern here is that 2013 has been a terrible year for oil-by-rail; the recent disaster in Canada isn't the only derailment. Canadian Pacific (NYSE: CP ) had three derailments involving oil tank cars in the first four months of this year. One of the accidents, in Minnesota, resulted in 30,000 gallons of oil being spilled. It remains to be seen if these spills will be the tipping point for the approval of additional pipeline projects.
- [By Marshall Hargrave]
Has the market lost faith in Ackman that quickly? Granted, the media has had a field day over the J.C. Penney (NYSE: JCP) debacle, not to mention the virtual implosion of his Herbalife (NYSE: HLF) short. However, Ackman is coming off one of his biggest wins with Canadian Pacific Railway (NYSE: CP), which also happens to be in the industrials sector. His Pershing Square hedge fund managed to make 2.5 times its money in just around two years at Canadian Pacific.
- [By Arjun Sreekumar]
Not surprisingly, Union Pacific (NYSE: UNP ) , one of largest rail companies in the U.S., tripled the amount of crude oil it shipped last year, while Berkshire Hathaway's (NYSE: BRK-B ) Burlington Northern Santa Fe, or BNSF, another rail giant, is currently moving about 650,000 barrels of crude oil per day, up from next to nothing just five years ago. And Canadian Pacific Railway (NYSE: CP ) expects to ship some 70,000 carloads of crude this year, up from just 500 in 2009.
- [By Jon C. Ogg]
Canadian Pacific Railway Ltd. (NYSE: CP) was upgraded to Outperform from Neutral and the price target was raised to $144 from $139 at Credit Suisse.
Top 10 Healthcare Equipment Stocks To Buy For 2014: DiaMedica Inc (DMA)
DiaMedica Inc. (DiaMedica) is a development-stage company. The Company is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of diabetes and related diseases. DiaMedica's compound, DM-199, is a recombinant human protein for the treatment of both Type I and Type II diabetes and their complications. DiaMedica is starting a Phase I/II clinical trial for DM-199. DM-199 is a recombinant human protein, which improves glucose control, protects beta cells through the expansion of a population of antigen-specific immunosuppressive cells (Tregs), and proliferates insulin producing beta cells through the activation of certain growth factors. The Company�� DM-204 is a G-protein-coupled receptor agonist (GPCR) monoclonal antibody to treat Type II diabetes and some of the associated complication's. activating a receptor resulted in insulin sensitivity, insulin secretion and vasodilation. Advisors' Opinion:- [By Richard Rhodes]
Given this economic backdrop, and developing pressure on corporate revenues, margins, and earnings, we feel that risk is being misplaced at current levels.
The 14-day and 40-day models are now overbought. Now, the 14-day and 40-day are peaking, which would certainly indicate a correction stands as the highest probability.
The % of stocks above their 10-day moving average (dma) is at the 70%-level; still a major divergence with prices.
The % of stocks above their 200-dma stands at 77%. The 87% level marked previous highs. The 50-dma/150-dma cross breakdown now confirms a larger correction. Bottoms form between 30%-40%.
Overall, the risk-reward remains skewed to the downside, regardless of whether prices remain above trendline resistance, as our model group suggests a correction to the 110-day moving average, currently at S&P 1711.
A clear breakdown at that level would accelerate the decline towards the wide 200-dma and 380-dma range, between 1657-1571.
No comments:
Post a Comment